Regeneron Pharmaceuticals
REGN
REGN
930 hedge funds and large institutions have $57.9B invested in Regeneron Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 198 funds opening new positions, 383 increasing their positions, 242 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
13.85% more ownership
Funds ownership: 70.07% → 83.92% (+14%)
14% more funds holding in top 10
Funds holding in top 10: 22 → 25 (+3)
0% more call options, than puts
Call options by funds: $1.08B | Put options by funds: $1.08B
Holders
930
Holding in Top 10
25
Calls
$1.08B
Puts
$1.08B
Top Buyers
| 1 | +$2.27B | |
| 2 | +$1.81B | |
| 3 | +$912M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$812M |
| 5 |
State Street
Boston,
Massachusetts
|
+$530M |
Top Sellers
| 1 | -$619M | |
| 2 | -$160M | |
| 3 | -$132M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$112M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$109M |